Virtu Financial »

Crispr Therapeutics shares owned by Virtu Financial

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Virtu Financial from 13F filings

Historical chart of Virtu Financial investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by Virtu Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by Virtu Financial

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.9M 31k 62.60
2023-09-30 $621k 14k 45.41
2023-06-30 $1.5M 27k 56.13
2022-09-30 $900k 14k 65.33
2022-06-30 $3.4M 56k 60.77
2022-03-31 $1.4M 22k 62.77
2021-12-31 $824k 11k 75.76
2021-03-31 $2.6M 21k 121.86
2018-03-31 $245k 5.4k 45.78